AN ACT to clarify the appropriate measurement of pseudoephedrine products for purposes of the pseudoephedrine transaction limits, and to clarify the identification and electronic record-keeping requirements for pseudoephedrine products, as recommended by the house select committee on methamphetamine abuse.

The General Assembly of North Carolina enacts:

SECTION 1.  G.S. 90‑113.53 reads as rewritten:
"§ 90‑113.53.  Pseudoephedrine transaction limits.
(a)	No person shall deliver to any one person, attempt to deliver to any one person, purchase, or attempt to purchase at retail more than 3.6 grams of any pseudoephedrine products per calendar day. This limit does not apply if the product is dispensed under a valid prescription.
(b)	No person shall purchase at retail more than 9 grams of pseudoephedrine products within any 30‑day period. This limit does not apply if the product is dispensed under a valid prescription.
(c)	This section does not apply to any pseudoephedrine products that are in the form of liquids, liquid capsules, gel capsules, or pediatric products labeled pursuant to federal regulation primarily intended for administration to children under 12 years of age according to label instruction, except as to those specific products for which the Commission issues an order pursuant to G.S. 90‑113.58 subjecting the product to requirements under this Article."
SECTION 2.  G.S. 90‑113.52(c) reads as rewritten:
"(c)	A pseudoephedrine product may be sold at retail without a prescription only to a person at least 18 years of age. The retailer shall require every retail purchaser of a pseudoephedrine product to furnish a valid, unexpired, government-issued photo identification and to provide, in print or orally, a current valid personal residential address. If the retailer has reasonable grounds to believe that the prospective purchaser is under 18 years of age, the retailer shall require the prospective purchaser to furnish photo identification showing the date of birth of the person. The name and address of every purchaser shall be entered in a record of disposition of pseudoephedrine products to the consumer on a form approved by the Commission. The record of disposition shall also identify each pseudoephedrine product purchased, including the number of grams the product contains and the purchase date of the transaction. The retailer shall require that every purchaser sign the form attesting to the validity of the information. The form approved by the Commission shall be constructed so that it allows for entry of information in electronic format, including electronic signature. The form shall also be constructed and maintained so as to minimize disclosure of personal information to unauthorized persons."
SECTION 3.  This act is effective when it becomes law.
In the General Assembly read three times and ratified this the 14th day of June, 2012.

	s/	 Walter H. Dalton
	 President of the Senate

	s/	 Thom Tillis
	 Speaker of the House of Representatives

	_____________________________________
		 Beverly E. Perdue
	 Governor

Approved __________.m. this ______________ day of ___________________, 2012